AbbVie
ABBV
ABBV
3,861 hedge funds and large institutions have $293B invested in AbbVie in 2025 Q3 according to their latest regulatory filings, with 292 funds opening new positions, 1,634 increasing their positions, 1,458 reducing their positions, and 104 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
12% more repeat investments, than reductions
Existing positions increased: 1,634 | Existing positions reduced: 1,458
3% more funds holding
Funds holding: 3,751 → 3,861 (+110)
1.08% less ownership
Funds ownership: 72.9% → 71.81% (-1.1%)
Holders
3,861
Holding in Top 10
213
Calls
$4.29B
Puts
$3.71B
Top Buyers
| 1 | +$2B | |
| 2 | +$410M | |
| 3 | +$407M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$357M |
| 5 |
Amundi
Paris,
France
|
+$326M |
Top Sellers
| 1 | -$682M | |
| 2 | -$468M | |
| 3 | -$424M | |
| 4 |
BlackRock
New York
|
-$342M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$286M |